Document used for the assessment of the expectedness of all ‘suspected’ serious adverse reactions that occur in clinical trials. It is recommended to include this information either in a subsection on Safety under ‘Effects in Humans’ or in the section ‘Summary of Data and Guidance for the Investigator’, in accordance with ICH E6 (R2) guidance.